TREATMENT PHARMA ApS: Financial statements 2023
CVR: 37208035
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
TREATMENT PHARMA ApS (CVR 37208035) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -44,723 and a net result of DKK -47,171 compared with DKK -23,841 the year before. Equity in the 2023 report amounted to DKK -76,174. The company had 1 employee in the financial year.
- Gross Profit
- DKK -44,723
- Profit/Loss
- DKK -47,171
- Equity
- DKK -76,174
- Total Assets
- DKK 70,171
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -45 t. | -47 t. | -76 t. | 1 |
| 2022 | - | -23 t. | -24 t. | -29 t. | - |
| 2021 | - | -3 t. | -3 t. | -5 t. | - |
| 2020 | - | -3 t. | 163 t. | -3 t. | - |
| 2019 | - | -3 t. | -5 t. | -165 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
TREATMENT PHARMA ApS has published its annual report for 2022. Gross profit came to DKK -22,856, and the net result was DKK -23,841.
About TREATMENT PHARMA ApS
TREATMENT PHARMA ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2015. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named TREATMENT ApS. The management consists of Anne Simmenæs. The company is owned by Tove Resen Holding ApS, Power the Future ApS and Anne Simmenæs Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 410,337 and a net result of DKK 101,980 compared with DKK -38,290 the year before. Equity in the 2025 report amounted to DKK 187,516.